Common Contracts
4 similar Investors’ Rights Agreement contracts by Deciphera Pharmaceuticals, Inc., Laird Superfood, Inc., PureTech Health PLC
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • October 27th, 2020 • PureTech Health PLC • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 30th day of June, 2020, by and among Vor Biopharma Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 15th, 2020 • Laird Superfood, Inc. • Food and kindred products • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 13th day of April, 2020, by and among Laird Superfood, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
EX-4.2 4 d364141dex42.htm EX-4.2 EXECUTION VERSION DECIPHERA PHARMACEUTICALS, LLC SECOND AMENDED & RESTATED INVESTORS’ RIGHTS AGREEMENT Page Schedule A - Schedule of Investors SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 5th, 2020 • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 26th day of May, 2017, by and among Deciphera Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”) and the successor in interest to Deciphera Pharmaceuticals, LLC, a Kansas limited liability company, each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”. Reference is hereby made to the Company’s Third Amended and Restated Operating Agreement, dated as of even date herewith, by and among the parties named therein, as such agreement may be amended from time to time (the “Operating Agreement”).
DECIPHERA PHARMACEUTICALS, LLC SECOND AMENDED & RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • September 11th, 2017 • Deciphera Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 26th day of May, 2017, by and among Deciphera Pharmaceuticals, LLC, a Delaware limited liability company (the “Company”) and the successor in interest to Deciphera Pharmaceuticals, LLC, a Kansas limited liability company, each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”. Reference is hereby made to the Company’s Third Amended and Restated Operating Agreement, dated as of even date herewith, by and among the parties named therein, as such agreement may be amended from time to time (the “Operating Agreement”).
